Interestingly, we found a higher percentage of CD11c+ DCs expressing CCR2 in the untreated mice (Supplementary Figure 7B) consistent with a study showing higher chemoattractant receptor expression in mDCs of MS patients35. Here, CCR2 is linked to myeloid sarcoma.